Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as David Emerson Jorden. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Charles E. Sheedy - $200K of AURX open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is David Emerson Jorden?
David Emerson Jorden is a corporate insider, tracked as CEO/CFO, Director of Nuo Therapeutics, Inc. (AURX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David Emerson Jorden submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has David Emerson Jorden been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($300K) across all tracked filings.
Where can I see all of David Emerson Jorden's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow David Emerson Jorden and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
